Pravastatin Supplier-Buyer Network — Trade Flow Analysis

Name: Pravastatin Supplier-Buyer Trade Network Dataset — 20+ Indian Exporters, 15+ Importers, 17+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Pravastatin supplier network, Pravastatin buyers, pharmaceutical export India, Pravastatin trade data

TransData Nexus

Pravastatin

India Pharmaceutical Trade Intelligence

$31.2M20 Suppliers17 CountriesHS 30049099

ExportsIndia → UNITED STATES26.0%India → CANADA23.6%

ImportsHUNGARY → India$17.5K CANADA → India$5.6K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: MYLAN HUNGARY

Who Supplies Pravastatin? Top Manufacturers & Buyers 2026 — INTAS PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the first-largest Pravastatin exporter from India, with a market share of 22.7% and a total export value of $7.1M across 37 shipments. Their average shipment value of $191.1K is above the market average of $49.2K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN HUNGARY KFT, is the dominant customer, accounting for 89.0% of this supplier's tracked business. Top customers include:

• MYLAN HUNGARY KFT, — $6.3M across 33 shipments (89.0% of this supplier's total exports)

• MYLAN HUNGARY KFT MYLAN U — $409.8K across 2 shipments (5.8% of this supplier's total exports)

• MYLAN HUNGARY KFT, — $284.3K across 1 shipments (4.0% of this supplier's total exports)

• MYLAN HUNGARY KFT — $72.2K across 0 shipments (1.0% of this supplier's total exports)

• MYLAN U 2 — $13.8K across 0 shipments (0.2% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $191.1K is 289% above the market average of $49.2K, consistent with large-order contracts or value-added formulations.

2INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the second-largest Pravastatin exporter from India, with a market share of 21.1% and a total export value of $6.6M across 122 shipments. Their average shipment value of $54.0K is above the market average of $49.2K, suggesting premium or bulk contract pricing.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. MANTRA DISTRIBUTIONS INC is the dominant customer, accounting for 91.6% of this supplier's tracked business. Top customers include:

• MANTRA DISTRIBUTIONS INC — $6.0M across 112 shipments (91.6% of this supplier's total exports)

• TO THE ORDER — $237.8K across 4 shipments (3.6% of this supplier's total exports)

• GALENICUM HEALTH S.L. — $139.4K across 3 shipments (2.1% of this supplier's total exports)

• TO THE ORDER — $90.7K across 2 shipments (1.4% of this supplier's total exports)

• GALENICUM HEALTH S.L. — $89.0K across 2 shipments (1.3% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $54.0K is 10% above the market average of $49.2K, consistent with large-order contracts or value-added formulations.

3MEDREICH LIMITED

MEDREICH LIMITED is the third-largest Pravastatin exporter from India, with a market share of 13.9% and a total export value of $4.3M across 41 shipments. Their average shipment value of $105.5K is above the market average of $49.2K, suggesting premium or bulk contract pricing.

MEDREICH LIMITED serves 4 named buyers in our database. MEIJI SEIKA PHARMATECH CO LTD is the dominant customer, accounting for 59.8% of this supplier's tracked business. Top customers include:

• MEIJI SEIKA PHARMATECH CO LTD — $2.6M across 25 shipments (59.8% of this supplier's total exports)

• MEIJI SEIKA PHARMATECH CO LTD — $1.3M across 12 shipments (29.4% of this supplier's total exports)

• MEIJI SEIKA PHARMATECH CO LTD — $466.3K across 4 shipments (10.8% of this supplier's total exports)

• MEIJI SEIKA PHARMATECH CO LTD — $488 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: MEDREICH LIMITED's per-shipment value of $105.5K is 115% above the market average of $49.2K, consistent with large-order contracts or value-added formulations.

4GLENMARK PHARMACEUTICALS LIMITED

GLENMARK PHARMACEUTICALS LIMITED is the fourth-largest Pravastatin exporter from India, with a market share of 10.2% and a total export value of $3.2M across 112 shipments. Their average shipment value of $28.4K is below the market average of $49.2K, reflecting a high-volume, competitive pricing strategy.

GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• UPS SUPPLY CHAIN — $1.6M across 56 shipments (49.6% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC USA — $457.4K across 16 shipments (14.4% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER 8912. — $415.1K across 15 shipments (13.1% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER 8912. — $372.7K across 13 shipments (11.7% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC USA — $357.0K across 13 shipments (11.2% of this supplier's total exports)

Key Insight: GLENMARK PHARMACEUTICALS LIMITED operates with high shipment frequency (112 shipments) at a per-shipment value of $28.4K, indicating a broad distribution network with many smaller, regular orders.

5STRIDES PHARMA SCIENCE LIMITED

STRIDES PHARMA SCIENCE LIMITED is the fifth-largest Pravastatin exporter from India, with a market share of 3.1% and a total export value of $978.7K across 111 shipments. Their average shipment value of $8.8K is below the market average of $49.2K, reflecting a high-volume, competitive pricing strategy.

STRIDES PHARMA SCIENCE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ARROW PHARMACEUTICALS PTY LTD., — $285.1K across 32 shipments (29.1% of this supplier's total exports)

• ARROW PHARMACEUTICALS PTY LTD., — $190.2K across 22 shipments (19.4% of this supplier's total exports)

• APOTEX PTY LTD., — $181.7K across 21 shipments (18.6% of this supplier's total exports)

• APOTEX PTY LTD., — $166.6K across 19 shipments (17.0% of this supplier's total exports)

• APOTEX PTY LTD., — $155.0K across 18 shipments (15.8% of this supplier's total exports)

Key Insight: STRIDES PHARMA SCIENCE LIMITED operates with high shipment frequency (111 shipments) at a per-shipment value of $8.8K, indicating a broad distribution network with many smaller, regular orders.

6EMCURE PHARMACEUTICALS LIMITED

EMCURE PHARMACEUTICALS LIMITED is the fifth-largest Pravastatin exporter from India, with a market share of 2.0% and a total export value of $608.6K across 89 shipments. Their average shipment value of $6.8K is below the market average of $49.2K, reflecting a high-volume, competitive pricing strategy.

EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MARCAN PHARMACEUTICALS INC., — $247.3K across 36 shipments (40.6% of this supplier's total exports)

• MARCAN PHARMACEUTICALS INC., — $220.0K across 32 shipments (36.2% of this supplier's total exports)

• MARCAN PHARMACEUTICALS INC., — $141.2K across 21 shipments (23.2% of this supplier's total exports)

• SINDHOOR TALASILA — $74 across 0 shipments (0.0% of this supplier's total exports)

• MARCAN PHARMA. — $7 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: EMCURE PHARMACEUTICALS LIMITED operates with high shipment frequency (89 shipments) at a per-shipment value of $6.8K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Pravastatin imports from India, with a total trade value of $8.1M across 102 shipments — representing a 26.0% share of all Pravastatin exports. The average shipment value of $79.4K is above the global average of $49.2K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.

Named Pravastatin importers in United States: GLENMARK PHARMACEUTICALS INC., USA is the largest buyer, accounting for 41.4% ($3.3M) of this market's total imports.

• GLENMARK PHARMACEUTICALS INC., USA — $3.3M (41.4% of United States's total)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $1.2M (14.3% of United States's total)

• GLENMARK PHARMACEUTICALS INC USA — $629.2K (7.8% of United States's total)

Key Insight: United States's per-shipment average of $79.4K (61% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Pravastatin imports from India.

Primary Market

Secondary Market

2Canada

Canada ranks as the second-largest destination for Pravastatin imports from India, with a total trade value of $7.4M across 100 shipments — representing a 23.6% share of all Pravastatin exports. The average shipment value of $73.6K is above the global average of $49.2K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Pravastatin importers in Canada: MANTRA DISTRIBUTIONS INC is the largest buyer, accounting for 82.0% ($6.0M) of this market's total imports.

• MANTRA DISTRIBUTIONS INC — $6.0M (82.0% of Canada's total)

• APOTEX INC — $409.3K (5.6% of Canada's total)

• MARCAN PHARMACEUTICALS INC. — $388.4K (5.3% of Canada's total)

Key Insight: Canada's per-shipment average of $73.6K (50% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Pravastatin imports from India.

Primary Market

Secondary Market

3Hungary

Hungary ranks as the third-largest destination for Pravastatin imports from India, with a total trade value of $7.1M across 30 shipments — representing a 22.8% share of all Pravastatin exports. The average shipment value of $237.1K is above the global average of $49.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Pravastatin importers in Hungary: MYLAN HUNGARY KFT, is the largest buyer, accounting for 89.0% ($6.3M) of this market's total imports.

• MYLAN HUNGARY KFT, — $6.3M (89.0% of Hungary's total)

• MYLAN HUNGARY KFT MYLAN U — $409.8K (5.8% of Hungary's total)

• MYLAN HUNGARY KFT — $356.5K (5.0% of Hungary's total)

Key Insight: Hungary's per-shipment average of $237.1K (382% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Hungary is a key market for Pravastatin imports from India.

Primary Market

Secondary Market

4Japan

Japan ranks as the fourth-largest destination for Pravastatin imports from India, with a total trade value of $4.3M across 40 shipments — representing a 13.9% share of all Pravastatin exports. The average shipment value of $108.2K is above the global average of $49.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Pravastatin importers in Japan: MEIJI SEIKA PHARMATECH CO., LTD is the largest buyer, accounting for 59.8% ($2.6M) of this market's total imports.

• MEIJI SEIKA PHARMATECH CO., LTD — $2.6M (59.8% of Japan's total)

• MEIJI SEIKA PHARMATECH CO LIMITED — $1.3M (29.4% of Japan's total)

• MEIJI SEIKA PHARMATECH CO LTD — $466.3K (10.8% of Japan's total)

Key Insight: Japan's per-shipment average of $108.2K (120% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Japan is a key market for Pravastatin imports from India.

Primary Market

Secondary Market

5Australia

Australia ranks as the fifth-largest destination for Pravastatin imports from India, with a total trade value of $2.4M across 61 shipments — representing a 7.6% share of all Pravastatin exports. The average shipment value of $39.0K is below the global average of $49.2K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Pravastatin importers in Australia: ARROW PHARMACEUTICALS PTY LTD., is the largest buyer, accounting for 37.3% ($888.1K) of this market's total imports.

• ARROW PHARMACEUTICALS PTY LTD., — $888.1K (37.3% of Australia's total)

• APOTEX PTY LTD., — $501.2K (21.1% of Australia's total)

Key Insight: Australia receives frequent, smaller shipments of Pravastatin — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Australia is a key market for Pravastatin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Pravastatin.
2.Flow Mapping: 20 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 634 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 17 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

634 Verified Shipments

20 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Pravastatin

Pravastatin

Who Supplies Pravastatin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Pravastatin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Pravastatin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MYLAN LABORATORIES LIMITED

2INTAS PHARMACEUTICALS LIMITED

3MEDREICH LIMITED

4GLENMARK PHARMACEUTICALS LIMITED

5STRIDES PHARMA SCIENCE LIMITED

6EMCURE PHARMACEUTICALS LIMITED

From Indian Factories to Global Pharmacies — How Pravastatin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Pravastatin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Canada

3Hungary

4Japan

5Australia

People Also Ask — Pravastatin Supplier & Trade Network

Pravastatin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology